Skip to main content
  • Home
  • Scheme Overview

WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 06-02-2024
Asset Class:
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 2.36% As on (30-04-2024)
Status: Open Ended Schemes
Minimum Investment: 100.0
Minimum Topup: 100.0
Total Assets: 112.6 Cr As on (30-04-2024)
Turn over:
NAV (₹): 10.019
₹ 0.12 ( 1.1977%)
as on 10-05-2024
CAGR Since Inception - -0.53%
S&P BSE Healthcare TRI - 14.65%

Fund Managers

Piyush Baranwal, Ramesh Mantri, Dheeresh Pathak, Naitik Shah


Investment Objective

The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

PERFORMANCE of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Scheme Performance (%) Data as on - 10-05-2024

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth - - - - -0.53
S&P BSE Healthcare TRI 49.81 12.89 21.11 13.21 14.65
Equity: Sectoral-Pharma and Healthcare 47.31 13.23 23.25 15.24 17.65

RETURNS CALCULATOR for WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Key Performance and Risk Statistics of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth - - - - - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION

Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
WhiteOak Capital Pharma and Healthcare Fund Reg Gr 06-02-2024 0.0 0.0 0.0 0.0 0.0
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum 25-07-2018 51.94 28.18 14.98 24.86 0.0
ABSL Pharma and Healthcare Reg Gr 05-07-2019 50.58 24.64 12.53 0.0 0.0
SBI HEALTHCARE Opportunities Reg Gr 14-07-1999 50.51 30.09 15.22 23.78 15.38
Nippon India Pharma Fund Gr Gr 01-06-2004 48.48 25.59 13.39 23.61 16.8
Tata India Pharma & Healthcare Reg Gr 28-12-2015 48.1 25.45 14.29 22.69 0.0
DSP Healthcare Reg Gr 05-11-2018 48.09 28.28 15.5 26.33 0.0
UTI Healthcare Reg Gr 05-08-2005 46.32 23.57 11.62 21.5 13.54
Mirae Asset Healthcare Reg Gr 10-07-2018 44.16 22.28 12.81 24.17 0.0
ITI Pharma and Healthcare Fund Reg Gr 08-11-2021 42.56 22.87 0.0 0.0 0.0

Asset Allocation (%)

PORTFOLIO ANALYSIS of WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth

Portfolio as on

Top 10 Sectors in portfolio (%)

Top 10 Stocks in portfolio (%)

AMC partners we work with